PLAT and hemorrhagic stroke: Despite the modest effects of the poly-arginine peptides following permanent MCAO, it is still possible that these peptides have potential clinical application, especially in less severe forms of stroke, stroke associated with cerebral reperfusion treatments (tPA ± thrombectomy) and haemorrhagic stroke.